Inflammatory mechanisms in ischemic stroke: therapeutic approaches
Top Cited Papers
Open Access
- 17 November 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 7 (1), 97
- https://doi.org/10.1186/1479-5876-7-97
Abstract
Acute ischemic stroke is the third leading cause of death in industrialized countries and the most frequent cause of permanent disability in adults worldwide. Despite advances in the understanding of the pathophysiology of cerebral ischemia, therapeutic options remain limited. Only recombinant tissue-plasminogen activator (rt-PA) for thrombolysis is currently approved for use in the treatment of this devastating disease. However, its use is limited by its short therapeutic window (three hours), complications derived essentially from the risk of hemorrhage, and the potential damage from reperfusion/ischemic injury. Two important pathophysiological mechanisms involved during ischemic stroke are oxidative stress and inflammation. Brain tissue is not well equipped with antioxidant defenses, so reactive oxygen species and other free radicals/oxidants, released by inflammatory cells, threaten tissue viability in the vicinity of the ischemic core. This review will discuss the molecular aspects of oxidative stress and inflammation in ischemic stroke and potential therapeutic strategies that target neuroinflammation and the innate immune system. Currently, little is known about endogenous counterregulatory immune mechanisms. However, recent studies showing that regulatory T cells are major cerebroprotective immunomodulators after stroke suggest that targeting the endogenous adaptive immune response may offer novel promising neuroprotectant therapies.</pKeywords
This publication has 77 references indexed in Scilit:
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-GuérinJournal of Neuroscience, 2009
- Neuroprotection in stroke by complement inhibition and immunoglobulin therapyNeuroscience, 2009
- The Nrf2–ARE PathwayAnnals of the New York Academy of Sciences, 2008
- Cell adhesion molecules and ischemic strokeNeurological Research, 2008
- Brain-Mapping Techniques for Evaluating Poststroke Recovery and Rehabilitation: A ReviewTopics in Stroke Rehabilitation, 2008
- Pharmacokinetic modelling of interleukin‐1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhageBritish Journal of Clinical Pharmacology, 2007
- Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseJCI Insight, 2007
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006